Meanwhile, the tumor edge demonstrated lower CD8+ cell densities and less dispersion when compared to the IZ stroma aspect in the ER+HER2– BC subgroup (p < 0.0001) (Fig 2A); however, this difference did not reach statistical significance in TNBC patients (p = 0.14, Fig 2B). This evidence concerns the gene CD8A and breast cancer.